Anhui Huaheng Biotechnology Co., Ltd. (688639.SH): Net profit for 2024 is 200 million yuan, a decrease of 55.51% year-on-year.
Huaheng Biology (688639.SH) released its 2024 annual performance report announcement, during the reporting period, the company achieved operating revenue.
Anhui Huaheng Biotechnology Co., Ltd. (688639.SH) released its 2024 annual performance report, reporting a total operating income of 2.184 billion yuan, a year-on-year increase of 12.70%; a net profit attributable to the shareholders of the listed company of 200 million yuan, a year-on-year decrease of 55.51%; a net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses of 186 million yuan, a year-on-year decrease of 57.56%; and a basic earnings per share of 0.86 yuan/share.
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


